Randolph Taylor, MD
Family Medicine · Smyrna, GANPI 1386820553
Payments from drug & device makers
Across 53 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$222
- Gilead$191
- Viiv Healthcare Company$136
- Lilly USA, LLC$76
- AstraZeneca$65
- Johnson & Johnson$54
- plus $338 from 15 others
What the payments were for
- Food & beverage$1,081100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $222 |
| Gilead | 9 | $191 |
| Viiv Healthcare Company | 7 | $136 |
| Lilly USA, LLC | 3 | $76 |
| AstraZeneca | 4 | $65 |
| Johnson & Johnson(2 entities) | 2 | $54 |
| Kerecis Limited | 1 | $45 |
| Boehringer Ingelheim | 2 | $44 |
| Jazz Pharmaceuticals Inc. | 1 | $30 |
| Dynavax Technologies Corporation | 1 | $28 |
| Merck | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Echosens North America, Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| Abbott | 1 | $17 |
| GSK | 1 | $16 |
| Exact Sciences | 1 | $14 |
| AbbVie | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Shield Therapeutics Inc | 1 | $13 |
How this compares
$1,081 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 45 | $474 |
| Amlodipine Besylate | 42 | $215 |
| Levothyroxine Sodium | 18 | $182 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $177 |
| Gabapentin | 17 | $165 |
| Fluticasone Propionate | 14 | $163 |
| Lisinopril | 24 | $153 |
| Allopurinol | 12 | $107 |
| Losartan Potassium | 13 | $95 |
| Triamcinolone Acetonide | 13 | $68 |
| Metformin Hcl | 18 | $44 |
| Furosemide | 15 | $40 |
| Metoprolol Succinate | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Smyrna
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.